ADMETatlas — Peptide ADMET Evidence Atlas

Evidence entries

95records·43peptides

Showing reference-linked Tmax evidence with reported value, assay context, interpretation role, and reference access kept separate.

Assay context

Evidence role

All95 Curated comparable91 Reported4

#	Endpoint	Peptide		Assay context	Evidence role	Reference
1	Tmax Exposure / Absorption	ATLPC0011879	20-30 minutes 1,200-1,800 seconds	TGA Product Information 5.2 pharmacokinetic properties manual extractionplasmahumanintramuscular	Comparable	Open
2	Tmax Exposure / Absorption	ATLPC0011879	0.25-0.75 h 900-2,700 seconds	Canadian Product Monograph 10.3 pharmacokinetics manual extractionplasmahumanintramuscular	Comparable	Open
3	Tmax Exposure / Absorption	ATLPC0035830	2 h 7,200 seconds	Canadian Product Monograph Table 2 pharmacokinetics manual extractionserumhumanintramuscular50 mg intramuscular dose	Comparable	Open
4	Tmax Exposure / Absorption	ATLPC0035830	0.5-2 hours 1,800-7,200 seconds	Canadian Product Monograph detailed pharmacology manual extractionserumhumanintramuscularmultiple 2-4 mg/kg/day intramuscular dosing	Comparable	Open
5	Tmax Exposure / Absorption	ATLPC0015943	~ 1 hour ~ 3,600 seconds	UK eMC SmPC section 5.2 pharmacokinetics manual extractionserumhumansubcutaneous	Comparable	Open
6	Tmax Exposure / Absorption	ATLPC0020504	0.667 hrs 2,401.2 seconds	FDA Clinical Pharmacology Review Table 6 manual extractionplasmahumanintravenoussingle 140 mg dose infused over 30 min	Comparable	Open
7	Tmax Exposure / Absorption	ATLPC0020504	0.5 hrs 1,800 seconds	FDA Clinical Pharmacology Review Table 6 manual extractionplasmahumanintravenoussingle 220 mg dose infused over 30 min	Comparable	Open
8	Tmax Exposure / Absorption	ATLPC0020504	0.5 hrs 1,800 seconds	FDA Clinical Pharmacology Review Table 6 manual extractionplasmahumanintravenoussingle 350 mg dose infused over 30 min	Comparable	Open
9	Tmax Exposure / Absorption	ATLPC0020504	0.5 hrs 1,800 seconds	FDA Clinical Pharmacology Review Table 6 manual extractionplasmahumanintravenoussingle 500 mg dose infused over 30 min	Comparable	Open
10	Tmax Exposure / Absorption	ATLPC0020504	0.833 hrs 2,998.8 seconds	FDA Clinical Pharmacology Review Table 6 manual extractionplasmahumanintravenoussingle 630 mg dose infused over 30 min	Comparable	Open
11	Tmax Exposure / Absorption	ATLPC0020504	0.5 hrs 1,800 seconds	FDA Clinical Pharmacology Review Table 6 manual extractionplasmahumanintravenoussingle 840 mg dose infused over 30 min	Comparable	Open
12	Tmax Exposure / Absorption	ATLPC0020504	0.5 hrs 1,800 seconds	FDA Clinical Pharmacology Review Table 6 manual extractionplasmahumanintravenoussingle 1120 mg dose infused over 30 min	Comparable	Open
13	Tmax Exposure / Absorption	ATLPC0002714	20 minutes 1,200 seconds	PepTherDia curated product PK fieldIV	Comparable	Open
14	Tmax Exposure / Absorption	ATLPC0002714	13 minutes 780 seconds	PepTherDia curated product PK fieldIM	Comparable	Open
15	Tmax Exposure / Absorption	ATLPC0002714	15 minutes 900 seconds	PepTherDia curated product PK fieldNASAL	Comparable	Open
16	Tmax Exposure / Absorption	ATLPC0003634	~ 2 hours ~ 7,200 seconds	PepTherDia curated product PK fieldIM, SC	Comparable	Open
17	Tmax Exposure / Absorption	ATLPC0007218	<= 10 min <= 600 seconds	PepTherDia curated product PK fieldIV	Reported	Open
18	Tmax Exposure / Absorption	ATLPC0011948	12 hr 43,200 seconds	Tmax in Gottingen mini pig at 2 nmol/kg, scporcinesc	Comparable	Open
19	Tmax Exposure / Absorption	ATLPC0009237	0.63 hr 2,268 seconds	Tmax in cannulated Sprague-Dawley rat at 10 nmol, sc by EIAratsc	Comparable	Open
20	Tmax Exposure / Absorption	ATLPC0009237	0.8 hr 2,880 seconds	Tmax in Sprague-Dawley rat at 15 nmol/kg, sc by LC-MS/MS analysisratsc	Comparable	Open

1–20 / 95

Measurements

Browse by ADMET domain

Evidence entries